-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617.P1.66 617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster I

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A, Level 2 (Orange County Convention Center)

Matthew A. Kutny, MD1, Todd A. Alonzo, PhD2, Yi-Cheng Wang, MS3*, Rhonda Ries, MA4*, Jason E. Farrar, M.D.5, Jaime M. Guidry Auvil, PhD6*, Malcolm A. Smith, MD, PhD7, Daniela S. Gerhard, PhD6*, Tanja M. Davidsen, PhD6*, Patee Gesuwan6*, Leandro C. Hermida6*, Marco A Marra, PhD8, Andrew J. Mungall, PhD9, Richard Moore, PhD8*, William Long, PhD9*, Yussanne Ma, PhD9*, Stuart Zong9*, E. Anders Kolb, MD10, Alan S. Gamis, MD, MPH11 and Soheil Meshinchi, MD, PhD4

1Department of Pediatrics, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
2Keck School of Medicine, University of Southern California, Los Angeles, CA
3Children's Oncology Group, Monrovia, CA
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Department of Pediatics/Hematology Oncology Section, University of Arkansas for Medical Sciences, Little Rock, AR
6Office of Cancer Genomics, National Cancer Institute, Bethesda, MD
7Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
8Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
9Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
10Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE
11Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO

Jad Chahoud, MD1, Hagop M. Kantarjian, MD2, Farhad Ravandi, MD2, Koji Sasaki, MD2, Guillermo Garcia-Manero, MD2, Jorge E. Cortes, MD2, Tapan Kadia, MD2, Mark Brandt, BS3* and Elias Jabbour2

1University of Texas Hosuton Health Science Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Khaja Syed, M.S.1*, Christine Pietsch, Ph.D.1*, Amy Axel2*, Ann Forslund, Ph.D.1*, Kate Sasser, PhD3* and Mark Salvati, Ph.D.1*

1Janssen Research and Development, Spring House, PA
2Janssen Research & Development, LLC, Spring House, PA
3Heme Disease Area Stronghold, Janssen Pharmaceutical R&D, Spring House, PA

Claudia Haferlach, MD1, Kathleen Zieschang1*, Susanne Schnittger, PhD1, Tamara Alpermann1*, Melanie Zenger1*, Karolína Perglerová2*, Wolfgang Kern, MD1 and Torsten Haferlach1

1MLL Munich Leukemia Laboratory, Munich, Germany
2MLL2 s.r.o., Praha, Czech Republic

Tamara Alpermann*, Claudia Haferlach, MD, Annette Fasan, PhD*, Sonja Schindela*, Wolfgang Kern, MD and Torsten Haferlach

MLL Munich Leukemia Laboratory, Munich, Germany

Simone Weber1*, Tamara Alpermann1*, Karolína Perglerová2*, Susanne Schnittger, PhD1, Torsten Haferlach1, Claudia Haferlach, MD1 and Wolfgang Kern, MD1

1MLL Munich Leukemia Laboratory, Munich, Germany
2MLL2 s.r.o., Praha, Czech Republic

Adam Lamble, MD1, Yoko Kosaka, PhD2*, Pierrette Lo, MS3*, Fei Huang, PhD4*, Kate Sasser, PhD4*, Cristina E. Tognon, PhD5,6*, Marc Loriaux, MD, PhD7*, Jeffrey W. Tyner, PhD3, Brian J. Druker, MD3,6 and Evan F. Lind, PhD2,3*

1Pediatric Hematology/Oncology, Oregon Health & Science University, Portland, OR
2Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR
4Heme Disease Area Stronghold, Janssen Pharmaceutical R&D, Spring House, PA
5Knight Cancer Institute, Oregon Health and Science University, Portland, OR
6Howard Hughes Medical Institute, Portland, OR
7Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR

Michele Cea, MD1*, Antonia Cagnetta, MD1*, Davide Lovera, MD1*, Raffaella Grasso, PhD2*, Nicoletta Colombo, PhD2*, Micaela Bergamaschi, MD1*, Sara Aquino, MD3*, Fabio Guolo, MD2*, Paola Minetto, MD2*, Filippo Ballerini, MD2*, Letizia Canepa, MD1*, Sophia Adamia, PhD4, Alessio Nencioni1*, Ivana Pierri, MD5*, Marino Clavio6*, Maurizio Miglino, PhD2*, Marco Gobbi, MD2* and Roberto Massimo Lemoli, MD2

1University of Genoa, Genoa, Italy
2Chair of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy
3University of Genoa, genoa, Italy
4Dana-Farber Cancer Institute, Boston, MA
5Hematology Clinic, IRCSS AOU S.Martino-IST, University of Genova, Genova, Italy
6Hematology, S. Martino University Hospital, Genova, Italy

Esther Onecha1*, Joan Ballesteros2, Jose L Rojas2*, Jose M Sanchez1*, Eva Barragan, PhD3*, Inmaculada Rapado, PhD1*, Santiago Barrio4*, David Martinez, MD, PhD5*, Pau Montesinos, MD6*, Pilar Herrera, MD, PhD7*, Carmen Burgaleta, MD8*, Joaquin Martinez-López, MD.PhD9* and Rosa M. Ayala, MD, PhD1

1Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
2Vivia Biotech, Madrid, Spain
3Clinical Pathology Service; Hospital Universitari y Politecnic La Fe, Valencia, Spain
4Mayo Clinic, Scottsdale, AZ
5Hematology, Hospital Universitario de la Fe, Valencia, Spain
6Hematology, Hospital Universitari i Politčcnic La Fe de Valencia, Valencia, Spain
7Hospital Universitario Ramón y Cajal, Madrid, Spain
8Hematology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain
9Hematology, Hospital 12 de Octubre, Madrid, Spain

Andrew P. Voigt1*, Lisa Eidenschink Brodersen, PhD1*, Robert B. Gerbing, MA2*, Andrew J. Menssen1*, Betsy A. Hirsch, PhD2,3*, Susana C. Raimondi, PhD2,4, Alan S. Gamis, MD, MPH2,5, Todd A. Alonzo, PhD2,6, Soheil Meshinchi, MD, PhD2,7 and Michael R. Loken, PhD1*

1Hematologics Inc., Seattle, WA
2Children's Oncology Group, Monrovia, CA
3University of Minnesota Medical Center, Minneapolis, MN
4Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
5Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO
6Keck School of Medicine, University of Southern California, Los Angeles, CA
7Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Jingjing Xie, PhD1*, Zhigang Lu1* and Chengcheng Zhang, PhD2

1UT Southwestern, Dallas
2Deparment of Physiology, University of Texas Southwestern Medical Center, Dallas, TX

Lucy Chilton, PhD1*, Christine Harrison, PhD FRCPath FMedSci1, Anthony V. Moorman, PhD1, Iona Ashworth2*, Alan K. Burnett, MD, FRCP3, David Grimwade, PhD, FRCPath4 and Robert K Hills, MA MSc DPhil5

1Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
2Cardiff University School of Medicine, Cardiff, United Kingdom
3Haematology, Haematology, NCRI Working Group, United Kingdom, Cardiff, United Kingdom
4Dept of Medical & Molecular Genetics, King's College London School of Medicine, London, United Kingdom
5Haematology, Cardiff University School of Medicine on behalf of the NCRI AML Working Group, Cardiff, United Kingdom

Genki Yamato, MD1,2*, Norio Shiba, MD, PhD1,2*, Yusuke Hara, MD1,2*, Myoung-Ja Park, MD, PhD1*, Manabu Sotomatsu3*, Kentaro Ohki, MD, PhD4*, Hitoshi Ichikawa, PhD5*, Daisuke Tomizawa, MD, PhD6, Takashi Taga, MD, PhD7*, Keizo Horibe, MD, PhD8, Akio Tawa, MD, PhD9*, Hirokazu Arakawa, MD, PhD2*, Souichi Adachi, MD, PhD10 and Yasuhide Hayashi, MD, PhD1,11

1Department of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan
2Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan
3Hematology/Oncology, Gunma Children's Medical Center, shibukawa, Japan
4Departmentof Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan
5Cancer Transcriptome Project, National Cancer Center, Tokyo, Japan
6Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
7Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
8Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
9Department of Pediatrics, National Hospital Organization, Osaka National Hospital, Osaka, Japan
10Department of Human Health Sciences, Kyoto University, Kyoto, Japan
11Japanese Red Cross Gunma Blood Center, Maebashi, Japan

Silke Kapp-Schwoerer, MD1*, Sibylle Cocciardi1*, Jan Kroenke, MD1*, Anna Dolnik, PhD1*, Tamara J. Blätte1*, Andrea Corbacioglu, PhD1*, Verena I. Gaidzik, MD1*, Peter Paschka, MD1, Maria-Veronica Teleanu, MD1*, Karlheinz Holzmann, PhD2*, Gudrun Göhring, MD3*, Felicitas Thol, MD4, Michael Heuser, MD4, Arnold Ganser, MD, PhD4, Richard F. Schlenk, MD1, Hartmut Döhner, Prof. Dr.1, Lars Bullinger, MD1 and Konstanze Döhner, MD1

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2University of Ulm, Genomics Core Facility, Ulm, Germany
3Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany
4Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

Anna Hecht1*, Daniel Nowak, MD2*, Florian Nolte2*, Verena Nowak2*, Julia Oblaender2*, Thomas Buechner3*, Karsten Spiekermann4, Wolf-Karsten Hofmann, MD1 and Eva Lengfelder, MD1*

1Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany
2Department of Hematology and Oncology, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany
3Department of Hematology/Oncology, University of Muenster, Muenster, Germany
4Department of Internal Medicine III, Ludwig- Maximilians- Universität München, Munich, Germany

Kezhi Huang1,2*, Min Yang1,2*, Zengkai Pan1*, Florian H. Heidel, MD3, Michaela Scherr, PhD1*, Matthias Eder, M.D.1*, Thomas Fischer, MD3, Guntram Buesche, MD4, Nils von Neuhoff, PhD5*, Arnold Ganser, M.D.1 and Zhixiong Li, MD1,2

1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
2Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany
3Department of Hematology and Oncology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany
4Department of Pathology, Hannover Medical School, Hannover, Germany
5Institute of Human Genetics, Hannover Medical School, Hannover, Germany

Hasan Mahmud, PhD*, Frank JG Scherpen*, Tiny Meeuwsen-de Boer*, Harm Jan Lourens* and Eveline S. de Bont

Department of Pediatric Oncology/Hematology, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

Wade L Schulz, MD, PhD1, Thomas JS Durant, MD1*, Henry Rinder, MD1, Christopher A Tormey, MD1,2*, Richard Torres, MD1*, Brian R Smith, MD1, Karl M Hager, PhD1*, John G Howe, PhD1 and Alexa J Siddon, MD1

1Department of Laboratory Medicine, Yale University, New Haven, CT
2Pathology and Laboratory Medicine Service, VA Connecticut Healthcare System, West Haven, CT

Amber Johnson1*, Ann Marie Bailey2*, Kenna Shaw1*, Jorge E. Cortes, MD3, Tapan Kadia, MD4, Elias J Jabbour, MD4, Farhad Ravandi, MD4, Funda Meric-Bernstam5*, Hagop M. Kantarjian, MD4, Gordon Mills6* and Gautam Borthakur, MD4

1Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, UT MD Anderson Cancer Center, Houston, TX
2Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, UT MD Anderson Cancer Center, Houston, TN
3Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Investigational Cancer Therapeutics, UT MD Anderson Cancer Center, Houston, TX
6Systems Biology, UT MD Anderson Cancer Center, Houston, TX

Philipp J Rauch, MD1,2*, Corinne Widmer, MD1*, Kristin Fritsch, MS1*, Jana M Ellegast, MD1*, Jeroen S Goede, MD1*, Peter J M Valk, PhD3, Hitoshi Takizawa, PhD1* and Markus G Manz, MD1

1Division of Hematology, University Hospital Zurich, Zurich, Switzerland
2Department of Medicine, Boston University School of Medicine, Boston, MA
3Department of Hematology, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Zeqiang Ma, PhD1*, Jason Gottwals2*, Hao Ho, MD/PhD1*, Kristina J. Fasig, MD3*, Heather Rietz, MD1*, Taylor Hartley, MD1*, Vladimir Kravstov, MD1*, David C. Spence, MD4, Dan Connor, MD1*, Ron Turnicky, DO1*, James Prescott, PhD1*, Patrick Lennon, PhD1*, Malini Sathanoori, PhD1*, Ian W. Flinn, MD, PhD5,6, Jesus G. Berdeja, MD5,6, William B. Donnellan, MD5,6, Scott Wheeler, PhD1*, Christopher Coldren, PhD1*, Pranil Chandra, DO1*, Sandeep Mukherjee, PhD1* and Terence Casey, MD1*

1PathGroup, Nashville, TN
2PathGroup, Brentwood, TN
3Pathgroup, Brentwood, TN
4Pathgroup Inc, Chattanooga, TN
5Sarah Cannon Research Institute, Nashville, TN
6Tennessee Oncology, PLLC, Nashville, TN

Joshua M. Jackson, MS1*, James Taylor, BS1*, Malgorzata Witek, PhD2*, Sally A. Hunsucker, PhD3*, Jennifer Paulsen Waugh, MD4*, Yuri D. Fedoriw, MD3, Thomas C. Shea, MD4, Steven A. Soper, PhD2* and Paul M. Armistead, MD, PhD3

1Department of Chemistry, University of North Carolina, Chapel Hill, NC
2Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC
3Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
4Department of Medicine, University of North Carolina, Chapel Hill, NC

Ritika Dutta, BS*, Bruce Tiu*, Arya Kaul*, Bryan Mitton, MD, PhD and Kathleen M. Sakamoto, MD, PhD

Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA

Costakis Frangou, PhD1,2*, Jason Den Haese, PhD3,4*, Jordan Warunek3*, Scott Portwood, MS, MBA3*, Norma J Nowak, PhD5*, Andrei V Gudkov, PhD2*, Katerina Gurova, PhD2*, Meir Wetzler, MD3 and Eunice S. Wang, MD3

1Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY
2Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY
3Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
4Math and Natural Sciences, D'Youville College, Buffalo, NY
5Department of Biochemistry, University of Buffalo, Buffalo, NY

Parsa Hodjat, MD1*, Kankana Ghosh, B. Pharm2*, Priyanka Priyanka, MPH3*, Beenu Thakral, MBBS, MD1*, Keyur P. Patel, MD, PhD1*, Mark Routbort, MD, PhD1*, Rashmi Kanagal-Shamana, MD1*, C. Cameron Yin, MD, PhD1, Zhuang Zuo, MD, PhD1*, Raja Luthra, PhD1* and Tariq Muzzafar, MD1

1Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
2The University of Texas, School of Public Health, Houston, TX
3Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX

Bo Lei*, Ju Bai*, Wanggang Zhang*, Aili He*, Yinxia Chen*, Pengyu Zhang*, Lu Qian* and Fuling Zhou*

Department of Hematology, Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China

Suning Chen1*, Nana Ping1*, Jia Yin1*, Wenxiu Cheng1*, Qinrong Wang1*, Qian Wang1*, Liang Ma1*, Hong Yao1*, Lijun Wen1*, Yang Xu1*, Hong Liu1*, Zhengming Jin1*, Mingqing Zhu1*, Jianying Liang1*, Dandan Liu1*, Huiying Qiu1*, Aining Sun, PhD1*, Changgeng Ruan, MD, PhD2 and Wu Depei, MD1

1Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China
2Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China

Sara Grace Rota, MSc1*, Paul A Spagnuolo, Ph.D.2, Leonard Angka1*, Andrew Doxey3*, Praveen Nekkar4* and Mark D. Minden, MD, PhD5

1University of Waterloo, Kitchener, ON, Canada
2School of Pharmacy, University of Waterloo, Waterloo, ON, Canada
3University of Waterloo, Waterloo, ON, Canada
4University of Waterloo, Kitchener, Canada
5Princess Margaret Cancer Centre, University Health Network, Leukemia Program, Division of Medical Oncology and Hematology, Toronto, ON, Canada

Robert K Hills, DPhil1, Claire M Lucas2*, Laura J Scott2*, Natasha Carmell2*, Alison K Holcroft2* and Richard E. Clark, MD3*

1Department of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom
2Depts of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
3Royal Liverpool University Hospital, Liverpool, United Kingdom

Marina Diaz-Beya, MD, PhD1*, Alfons Navarro2*, Anna Cordeiro3*, Marta Pratcorona4*, Joan Castellano2*, Miguel Angel Torrente5*, Meritxell Nomdedeu6*, Ruth Risueńo7*, Maria Rozman8*, Mariano Monzo2* and Jordi Esteve, MD, PhD9

1Hematology Department, Hospital Clinic, IDIBAPS Barcelona. Josep Carreras Leukemia Reseach Institute, Barcelona, Spain
2Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, Barcelona, Spain
32Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, Barcelona, Spain
4Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
5Hematology Department,Hospital Clinic Barcelona, IDIBAPS., Barcelona, Spain
6Hospital Clinic, Spanish MDS Cooperative Group, Barcelona, Spain
7Josep Carreras Leukaemia Research Institute, Barcelona, Spain
8Hospital Clínic, Barcelona, Spain
9Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain

Zhihong Zeng, MD1, Wenbin Liu, PhD2*, Twee Tsao, MS3*, Yihua Qiu, MD4*, Ismael Samudio, PhD5*, Keith Baggerly, PhD6*, Steven M. Kornblau, MD4, Hagop M Kantarjian, MD7, Michael Andreeff, MD, PhD8 and Marina Konopleva, MD, PhD1

1Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX
3Leukemia Department, MD Anderson Cancer Center, Houston, TX
4Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
5CDRD - The Centre for Drug Research and Development, Vancouver, Canada
6Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
8Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX

Tara L. Lin, MD1,2, Amanda Wise, MS2*, Abigale Berry2*, Joseph Fontes, PhD3*, Partha Kasturi, PhD4*, Brea C. Lipe, MD1,2 and Omar S. Aljitawi, MD1,2

1Division of Hematology/Oncology, University of Kansas Medical Center, Kansas City, KS
2Hematology and Transplantation Research Laboratory, University of Kansas Medical Center, Kansas City, KS
3Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS
4Department of Pharmacology, University of Kansas Medical Center, Kansas City, KS

Stephen Sze Yuen Lam1*, Chae Yin Cher2*, Nelson K. L. Ng2*, Cheuk Him Man, PhD1* and Anskar Y.H. Leung, MD2

1Department of Medicine, The University of Hong Kong, Hong Kong, China
2Department of Medicine, The University of Hong Kong, Hong Kong, Hong Kong

Croix Fossum, BS1, Rhett P. Ketterling, MD2*, Lindsey E. Roeker1*, Ajoy L. Dias, MD3*, Michelle Elliott, MD3*, William J. Hogan, MBChB3, Mark R. Litzow, MD3 and Aref Al-Kali, MD3

1Mayo Medical School, Rochester, MN
2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN

Heba M. Jalal El-Din1* and Jasmeen S. Merzaban, PhD2

1King Abdullah university of science and technology (Kaust), Thuwal, Saudi Arabia
2Division of Biological and Environmental Sciences & Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia

Carmen M Alonso*, MD1*, Marta Llop*, PhD2,3*, Mariam Ibáńez, PhD3,4*, Jose Cervera, MD4*, Esperanza Such, PhD4*, Eva Villamon3,4*, Sarai Palanca2*, Inmaculada de Juan2*, Rosa Murria2*, Blanca de Unamuno2*, Laia Pedrola3*, Ivan Martin3*, Pau Montesinos, MD4*, Pascual Bolufer2*, Miguel A. Sanz, MD, PhD4 and Eva Barragan, PhD2*

1Hematology Department, Hospital Arnau de Vilanova, Valencia, Spain
2Clinical Pathology Service; Hospital Universitari y Politecnic La Fe, Valencia, Spain
3Instituto de Investigación Sanitaria La Fe, Valencia, Spain
4Hematology Department, Hospital Universitari i Politecnic La Fe, Valencia, Spain

Subarna Sinha, PhD1*, Daniel Thomas, MD, PhD2, Steven M. Chan, MD, PhD3, Yang Gao4*, Rolf Jansen, PhD5*, Ravi Majeti, MD, PhD6 and David L Dill, PhD1*

1Computer Science, Stanford University, Palo Alto, CA
2Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, CA
3Stanford Cancer Institute, Stanford University, Stanford, CA
4Electrical Engineering and Computer Sciences, University of California at Berkeley, Berkeley, CA
5Helmholtz Center for Infection Research, Braunschweig, Germany
6Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA

Remco Molenaar, M.Sc.1,2*, Srinivasa Reddy Sanikommu, MD3, Bhumika J. Patel4*, Bartlomiej Przychodzen, MSc5*, Cornelis J van Noorden, PhD6*, Tomas Radivoyevitch, PhD7*, Hideki Makishima, MD, Ph.D.5,8, Hetty E. Carraway, MD, MBA9 and Jaroslaw P. Maciejewski, MD, PhD10

1Department of Cell Biology & Histology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
2Translational Hematology & Oncology Research, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
3Departemnt of Translational Hematology and Oncology, Cleveland Clinic Taussing Cancer Institute, Cleveland, OH
4Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
5Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH
6Department of Cell Biology & Histology, Academic Medical Center, Amsterdam, Netherlands
7Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
8Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
9Leukemia Program, Cleveland Clinic, Cleveland, OH
10Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Mohammad Omar Hussaini, MD1*, Haipeng Shao, M.D., Ph.D.1*, Lynn C. Moscinski, M.D.1 and Jinming Song, MD, PhD2*

1Dept. of Hematopathology, Moffitt Cancer Center, Tampa, FL
2Hematopathology, Moffitt Cancer Center, Tampa, FL

Chin-Hin Ng, MD, MRCP, FRCPATH1*, Ma Thin Mar Win, MBBS, MPH, MHM2*, Elaine Seah, BSc1* and Wee-Joo J Chng, MD, MRCP, FRCPATH, PhD1,3

1Department of Haematology-Oncology, National University Cancer Institute of Singapore, Singapore, Singapore
2Biostatistics Unit, Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore
3Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

Sylvia Herold, PhD1,2*, Michael Kramer, MSc.1*, Christoph Röllig, MD1*, Matthias Kuhn3*, Thoralf Stange3*, Uwe Platzbecker, MD1, Johannes Schetelig, MD, M.Sc4,5, Hubert Serve, MD6, Gerhard Ehninger, MD1 and Christian Thiede, MD7

1Medical Dept. 1, University Hospital TU Dresden, Dresden, Germany
2German Cancer Research Consortium (DKTK), Heidelberg, Germany
3Institute for Medical Informatics and Biometry, Dresden, Germany
4Medical Deptartment 1, University Hospital TU Dresden, Dresden, Germany
5DKMS German Bone Marrow Donor Center, Dresden, Germany
6Department for Hematology/Oncology, Goethe-University Hospital Frankfurt, Frankfurt am Main, Germany
7Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany

*signifies non-member of ASH